SOP for QA audit laboratory accreditation – Clinical Research Made Simple https://www.clinicalstudies.in Trusted Resource for Clinical Trials, Protocols & Progress Wed, 22 Oct 2025 17:06:51 +0000 en-US hourly 1 https://wordpress.org/?v=6.9.4 SOP for Local Lab Accreditation Verification and Documentation (India-Specific) https://www.clinicalstudies.in/sop-for-local-lab-accreditation-verification-and-documentation-india-specific/ Wed, 22 Oct 2025 17:06:51 +0000 ]]> https://www.clinicalstudies.in/?p=7088 Read More “SOP for Local Lab Accreditation Verification and Documentation (India-Specific)” »

]]>
SOP for Local Lab Accreditation Verification and Documentation (India-Specific)

{
“@context”: “https://schema.org”,
“@type”: “Article”,
“mainEntityOfPage”: {
“@type”: “WebPage”,
“@id”: “https://www.clinicalstudies.in/sop-for-local-lab-accreditation-verification-and-documentation-india-specific”
},
“headline”: “SOP for Local Lab Accreditation Verification and Documentation (India-Specific)”,
“description”: “This SOP defines standardized procedures for verifying and documenting local laboratory accreditations in Indian clinical trials. It ensures compliance with CDSCO/DCGI requirements, NABL certification checks, and archiving of accreditation records for regulatory inspections.”,
“author”: {
“@type”: “Organization”,
“name”: “ClinicalStudies.in”
},
“publisher”: {
“@type”: “Organization”,
“name”: “ClinicalStudies.in”,
“logo”: {
“@type”: “ImageObject”,
“url”: “https://www.clinicalstudies.in/logo.png”
}
},
“datePublished”: “2025-08-26”,
“dateModified”: “2025-08-26”
}

Standard Operating Procedure for Local Lab Accreditation Verification and Documentation (India-Specific)

SOP No. CR/OPS/148/2025
Supersedes NA
Page No. X of Y
Issue Date 26/08/2025
Effective Date 01/09/2025
Review Date 01/09/2026

Purpose

The purpose of this SOP is to outline the procedure for verifying and documenting the accreditation of local laboratories used in Indian clinical trials. This ensures compliance with DCGI/CDSCO and New Drugs and Clinical Trials Rules (NDCTR 2019), while safeguarding data integrity, reliability, and subject safety. Accreditation primarily refers to NABL (National Accreditation Board for Testing and Calibration Laboratories) certification or equivalent.

Scope

This SOP applies to sponsors, CROs, investigators, QA, and site staff responsible for selecting, verifying, and using local laboratories for clinical trial sample analysis in India. It covers accreditation verification, documentation, and maintenance of records in TMF and ISF for regulatory inspections.

Responsibilities

  • Sponsor: Ensures that all trial laboratories used are appropriately accredited and compliant with regulations.
  • CRO: Conducts verification of lab accreditation and communicates findings to the sponsor.
  • Investigator: Confirms that site laboratories hold valid accreditation.
  • QA: Audits lab records to ensure accreditation and inspection readiness.
  • Laboratory: Maintains valid accreditation and provides updated certificates.

Accountability

The Sponsor’s Regulatory Affairs and QA Heads are accountable for ensuring valid accreditation of laboratories used in Indian clinical trials and proper documentation of all certificates.

Procedure

1. Laboratory Selection and Verification
1.1 Obtain accreditation certificate (NABL or equivalent) from each laboratory.
1.2 Verify certificate validity on NABL website or issuing authority.
1.3 Record in Lab Accreditation Verification Log (Annexure-1).

2. Documentation
2.1 File accreditation certificates in TMF and ISF.
2.2 Maintain copies at sponsor and CRO levels.
2.3 Record in Accreditation Document Log (Annexure-2).

3. Renewal Tracking
3.1 Track certificate expiration dates.
3.2 Request updated accreditation certificates before expiry.
3.3 Record in Renewal Tracking Log (Annexure-3).

4. Non-Compliant Laboratories
4.1 Do not use non-accredited laboratories.
4.2 Document issues in Non-Compliance Log (Annexure-4).

5. Audit and Inspection
5.1 Maintain inspection-ready accreditation records.
5.2 Conduct periodic audits recorded in Lab Audit Log (Annexure-5).

Abbreviations

  • SOP: Standard Operating Procedure
  • EC: Ethics Committee
  • DCGI: Drugs Controller General of India
  • CDSCO: Central Drugs Standard Control Organization
  • NABL: National Accreditation Board for Testing and Calibration Laboratories
  • CRO: Contract Research Organization
  • QA: Quality Assurance
  • TMF: Trial Master File
  • ISF: Investigator Site File
  • NDCTR: New Drugs and Clinical Trials Rules

Documents

  1. Lab Accreditation Verification Log (Annexure-1)
  2. Accreditation Document Log (Annexure-2)
  3. Renewal Tracking Log (Annexure-3)
  4. Non-Compliance Log (Annexure-4)
  5. Lab Audit Log (Annexure-5)

References

Version: 1.0

Approval Section

Prepared By Ravi Kumar, Clinical Research Associate
Checked By Sunita Reddy, QA Officer
Approved By Dr. Anil Sharma, Head Clinical Operations

Annexures

Annexure-1: Lab Accreditation Verification Log

Date Lab Name Accreditation No. Verified By Status
01/09/2025 XYZ Path Labs NABL/2024/567 CRO Monitor Verified

Annexure-2: Accreditation Document Log

Date Lab Name Certificate Filed Filed By Status
02/09/2025 XYZ Path Labs Yes Reg Affairs Archived

Annexure-3: Renewal Tracking Log

Date Lab Name Certificate Expiry Status Checked By
05/09/2025 XYZ Path Labs 30/06/2026 Valid QA

Annexure-4: Non-Compliance Log

Date Lab Name Issue Reported By Status
07/09/2025 ABC Labs Accreditation Expired CRA Escalated

Annexure-5: Lab Audit Log

Date Audit Type Performed By Status
10/09/2025 Mock DCGI Inspection QA Compliant

Revision History

Revision Date Revision No. Revision Details Reason for Revision Approved By
26/08/2025 00 Initial version New SOP creation Head Clinical Operations

For more SOPs visit: Pharma SOP

]]>